Molecular Biology and Genomics — MCQs

Molecular Biology and Genomics Indian Medical PG Practice Questions and MCQs

Question 481: All are steps of PCR EXCEPT?

A. Denaturation
B. Annealing
C. Extension
D. Transformation (Correct Answer)

Explanation: **Explanation:** The **Polymerase Chain Reaction (PCR)** is an *in vitro* enzymatic technique used to amplify specific DNA sequences. It operates through a repetitive thermal cycling process consisting of three fundamental steps: 1. **Denaturation (Option A):** The double-stranded DNA template is heated (typically to **94–96°C**) to break the hydrogen bonds between bases, resulting in two single strands. 2. **Annealing (Option B):** The temperature is lowered (typically **50–65°C**) to allow synthetic oligonucleotide primers to bind (hybridize) to their complementary sequences on the single-stranded DNA. 3. **Extension/Elongation (Option C):** The temperature is raised (typically **72°C**), and a thermostable DNA polymerase (e.g., **Taq polymerase**) synthesizes a new DNA strand by adding dNTPs to the 3' end of the primers. **Why Transformation is the Correct Answer:** **Transformation (Option D)** is a process used in *in vivo* molecular cloning where a host cell (usually a bacterium like *E. coli*) takes up foreign extracellular DNA from its environment. It is not a step in the PCR thermal cycle. **High-Yield Clinical Pearls for NEET-PG:** * **Taq Polymerase:** Derived from the bacterium *Thermus aquaticus*; it is heat-stable, which is essential for surviving the denaturation phase. * **RT-PCR:** Uses Reverse Transcriptase to convert RNA into cDNA before amplification (Gold standard for diagnosing **COVID-19**). * **Real-Time PCR (qPCR):** Allows for the quantification of DNA in real-time using fluorescent dyes (e.g., SYBR Green). * **Components required:** Template DNA, Primers, dNTPs, Taq Polymerase, and $Mg^{2+}$ ions (cofactor).

Question 482: What is the primary use of a Punnett's square?

A. Random sampling
B. Statistical analysis
C. Determining the genotype of offspring (Correct Answer)
D. Test of significance

Explanation: ### Explanation **Correct Option: C. Determining the genotype of offspring** A **Punnett square** is a graphical representation used in genetics to predict the probability of an offspring having a particular genotype based on the genotypes of the parents. It works by aligning the maternal gametes on one axis and paternal gametes on the other. The intersecting boxes represent all possible combinations of alleles, allowing for the calculation of both **genotypic ratios** (e.g., 1:2:1 in a monohybrid cross) and **phenotypic ratios** (e.g., 3:1). In medical genetics, it is the fundamental tool for visualizing Mendelian inheritance patterns (Autosomal Dominant, Autosomal Recessive, and X-linked). **Why other options are incorrect:** * **A. Random sampling:** This is a technique used in research to select a representative group from a population to minimize bias. * **B. Statistical analysis:** While a Punnett square provides data that can be analyzed statistically (like Chi-square tests), the square itself is a predictive diagram, not a method of data analysis. * **D. Test of significance:** This refers to statistical tests (like p-values, t-tests, or ANOVA) used to determine if results are due to chance. The **Chi-square test** is often used *in conjunction* with Punnett square data to see if observed offspring ratios deviate significantly from expected Mendelian ratios. **High-Yield Clinical Pearls for NEET-PG:** * **Monohybrid Cross:** Phenotypic ratio is **3:1**; Genotypic ratio is **1:2:1**. * **Dihybrid Cross:** Phenotypic ratio is **9:3:3:1**. * **Test Cross:** Crossing an individual with a dominant phenotype but unknown genotype with a **homozygous recessive** individual. If any offspring show the recessive trait, the parent was heterozygous. * **Back Cross:** Crossing an F1 hybrid with one of the parents. * **Application:** Useful for calculating the risk of recurrence in genetic counseling for single-gene disorders (e.g., Cystic Fibrosis or Sickle Cell Anemia).

Question 483: Which is the most processive DNA polymerase?

A. DNA Polymerase I
B. DNA Polymerase II
C. DNA Polymerase III (Correct Answer)
D. None

Explanation: **Explanation:** **DNA Polymerase III** is the primary enzyme responsible for prokaryotic DNA replication. Its high **processivity**—defined as the ability of an enzyme to catalyze consecutive reactions without releasing its substrate—is its defining characteristic. 1. **Why DNA Polymerase III is correct:** DNA Pol III is a complex holoenzyme. Its high processivity (adding thousands of nucleotides per binding event) is attributed to the **$\beta_2$ clamp (sliding clamp)** subunit. This ring-shaped protein encircles the DNA strand, tethering the catalytic core to the template and preventing it from dissociating. This allows for the rapid and continuous synthesis of the leading strand and long fragments of the lagging strand. 2. **Why other options are incorrect:** * **DNA Polymerase I:** It has low processivity (adding only 20–50 nucleotides). Its primary roles are **primer removal** (via 5'→3' exonuclease activity) and filling short gaps during DNA repair and lagging strand maturation. * **DNA Polymerase II:** It is mainly involved in **DNA repair** (SOS response) when the replication fork is stalled. It has intermediate processivity but is significantly lower than Pol III. **High-Yield Clinical Pearls for NEET-PG:** * **Eukaryotic Counterpart:** In eukaryotes, **DNA Polymerase $\delta$ (delta)** and **$\epsilon$ (epsilon)** are the highly processive enzymes, utilizing the **PCNA** (Proliferating Cell Nuclear Antigen) as their sliding clamp. * **Exonuclease Activity:** DNA Pol III possesses **3'→5' exonuclease activity** for proofreading, ensuring high fidelity, but lacks the 5'→3' exonuclease activity found in Pol I. * **Speed:** DNA Pol III can add nucleotides at a rate of approximately 1,000 per second.

Question 484: A segment of a eukaryotic gene that is not represented in the mature messenger RNA is known as?

A. Intron (Correct Answer)
B. Exon
C. Plasmid
D. TATA box

Explanation: ### Explanation **Correct Answer: A. Intron** In eukaryotic gene expression, the initial transcript produced by RNA polymerase II is called **pre-mRNA** (or heterogeneous nuclear RNA, hnRNA). This precursor contains both coding and non-coding sequences. **Introns** are the non-coding "intervening" sequences that are removed during a post-transcriptional process called **splicing**. Because they are excised before the mRNA leaves the nucleus, they are not represented in the mature mRNA or the final protein product. **Analysis of Incorrect Options:** * **B. Exon:** These are the "expressed" sequences. Exons are joined together after introns are removed and form the continuous coding sequence of the mature mRNA that is translated into protein. * **C. Plasmid:** These are small, circular, extrachromosomal DNA molecules found primarily in bacteria. They are used as vectors in recombinant DNA technology but are not segments of a eukaryotic gene. * **D. TATA box:** This is a highly conserved **promoter element** located approximately 25–30 base pairs upstream of the transcription start site. It serves as a binding site for RNA polymerase II and transcription factors but is not transcribed into RNA. **High-Yield Clinical Pearls for NEET-PG:** * **Splicing Machinery:** Splicing is carried out by **snRNPs** (small nuclear ribonucleoproteins). Autoantibodies against snRNPs (specifically **Anti-Smith antibodies**) are highly specific for **Systemic Lupus Erythematosus (SLE)**. * **Alternative Splicing:** This process allows a single gene to code for multiple proteins by selectively including different exons (e.g., membrane-bound vs. secreted antibodies). * **Mutations:** Mutations at the **splice donor (GU)** or **splice acceptor (AG)** sites can lead to abnormal splicing, a common cause of diseases like **β-thalassemia**.

Question 485: On which chromosome is the ABO gene located?

A. 9q (Correct Answer)
B. 10p
C. 11q
D. 12p

Explanation: The ABO blood group system is determined by a single gene located on the **long arm (q) of chromosome 9**, specifically at the locus **9q34.2**. ### Explanation of the Correct Answer The ABO gene encodes a glycosyltransferase enzyme. Depending on the allele inherited (A, B, or O), this enzyme modifies the H antigen on the surface of red blood cells. * The **A allele** encodes α-1,3-N-acetylgalactosaminyltransferase. * The **B allele** encodes α-1,3-galactosyltransferase. * The **O allele** is a result of a frameshift mutation (deletion of Guanine at position 258), resulting in a non-functional protein. ### Analysis of Incorrect Options * **10p:** No major blood group systems are mapped to the short arm of chromosome 10. * **11q:** While chromosome 11 contains important clusters like the **Beta-globin gene**, it does not house the ABO locus. * **12p:** Chromosome 12 contains genes related to Von Willebrand Factor (12p13), but not the ABO system. ### High-Yield Clinical Pearls for NEET-PG * **H-Substance:** The precursor for A and B antigens is the H antigen, which is regulated by the **FUT1 gene** located on **Chromosome 19**. * **Bombay Phenotype:** Occurs when there is a deficiency of the H antigen (h/h genotype). These individuals type as "O" but have potent anti-H antibodies. * **Inheritance:** ABO blood groups follow **Codominance** (A and B are codominant) and **Mendelian inheritance**. * **Secretor Status:** Regulated by the **FUT2 gene**, also located on **Chromosome 19**.

Question 486: Which radiolabeled marker is best for studying DNA replication?

A. Ribose
B. Thymidine (Correct Answer)
C. Phosphate
D. Uracil

Explanation: ### Explanation **Correct Option: B. Thymidine** The study of DNA replication requires a marker that is **exclusive to DNA**. Thymidine is a nucleoside containing the nitrogenous base **Thymine**, which is found only in DNA and not in RNA. When cells are incubated with radiolabeled thymidine (usually $^3$H-Thymidine), it is incorporated into the newly synthesized DNA strands during the **S-phase** of the cell cycle. This allows researchers to measure the rate of DNA synthesis and visualize chromosomal replication via autoradiography. **Why the other options are incorrect:** * **A. Ribose:** This is the pentose sugar found in **RNA**. DNA contains deoxyribose. Using ribose would label RNA molecules, not DNA. * **C. Phosphate:** Phosphorus is present in the backbone of **both DNA and RNA**, as well as in phospholipids and ATP. It lacks the specificity required to isolate DNA replication specifically. * **D. Uracil:** This nitrogenous base is **unique to RNA** (replacing Thymine). Radiolabeled Uracil is the marker of choice for studying **transcription** (RNA synthesis), not DNA replication. **High-Yield Clinical Pearls for NEET-PG:** * **S-Phase Specificity:** Tritiated thymidine ($^3$H-TdR) is the gold standard for calculating the **Labeling Index**, which indicates the proliferative activity of a tumor. * **5-Fluorouracil (5-FU):** A common chemotherapy agent that acts by inhibiting **Thymidylate Synthase**, thereby blocking the synthesis of thymidine and halting DNA replication. * **Modern Alternative:** In contemporary labs, **BrdU (Bromodeoxyuridine)** is often used instead of radioactive thymidine; it is a thymidine analogue detected via immunohistochemistry.

Question 487: Which enzymes are involved in Base-excision repair?

A. DNA helicase II
B. ABC excinuclease
C. DNA polymerase I (Correct Answer)
D. DNA photolyase

Explanation: **Explanation:** **Base Excision Repair (BER)** is the primary mechanism for repairing non-bulky DNA damage, such as deaminated bases (e.g., Uracil), oxidized bases, or alkylated bases. The process follows a specific sequence: 1. **DNA Glycosylase:** Recognizes and removes the damaged base, creating an **AP site** (Apurinic/Apyrimidinic). 2. **AP Endonuclease:** Cleaves the phosphodiester backbone at the AP site. 3. **DNA Polymerase I:** In prokaryotes, this enzyme performs "nick translation." It uses its 5'→3' exonuclease activity to remove the damaged segment and its polymerase activity to fill the gap with correct nucleotides. (In eukaryotes, DNA Polymerase β performs this role). 4. **DNA Ligase:** Seals the final nick. **Analysis of Options:** * **Option A (DNA Helicase II):** Involved in **Methyl-directed Mismatch Repair (MMR)** in *E. coli* (MutHLS pathway) to unwind the DNA strand for degradation. * **Option B (ABC Excinuclease):** The hallmark enzyme of **Nucleotide Excision Repair (NER)**. It removes bulky lesions like pyrimidine dimers caused by UV light. * **Option D (DNA Photolyase):** Involved in **Direct Reversal** (Photoreactivation) of UV-induced damage. This enzyme is notably absent in placental mammals. **Clinical Pearls for NEET-PG:** * **Mnemonic for BER:** "GEL P" (Glycosylase, Endonuclease, Ligase, Polymerase). * **Defect in BER:** Mutations in *MUTYH* glycosylase lead to **MUTYH-associated polyposis (MAP)**, increasing colorectal cancer risk. * **Key distinction:** BER repairs **single base** damage, while NER repairs **bulky adducts** (distorting the helix).

Question 488: Which cytoplasmic process is involved during the processing of RNA precursors?

A. 5' capping
B. Poly (A) tailing
C. Methylation of tRNA
D. Attachment of CCA in tRNA (Correct Answer)

Explanation: **Explanation:** The processing of RNA precursors (post-transcriptional modification) occurs in different cellular compartments depending on the type of RNA and the specific modification involved. **Why Option D is Correct:** The addition of the **CCA sequence** to the 3' end of tRNA is a crucial maturation step. While some organisms encode this in the DNA, in eukaryotes, it is added post-transcriptionally by the enzyme **nucleotidyltransferase**. While initial tRNA processing begins in the nucleus, the final "quality control" and the attachment/repair of the CCA tail can occur in the **cytoplasm**. This CCA tail is essential because it serves as the attachment site for amino acids during translation (aminoacylation). **Analysis of Incorrect Options:** * **A. 5' capping:** This occurs exclusively in the **nucleus** shortly after transcription begins (co-transcriptional). It involves adding a 7-methylguanosine cap to protect mRNA from degradation. * **B. Poly (A) tailing:** This involves the addition of ~200 adenine nucleotides to the 3' end of mRNA. This process is mediated by Poly(A) polymerase and occurs in the **nucleus** before the mRNA is exported. * **C. Methylation of tRNA:** Base modifications, including methylation (e.g., producing thymidine or pseudouridine), primarily occur in the **nucleus** during the early stages of tRNA maturation. **High-Yield NEET-PG Pearls:** * **CCA Sequence:** Remember the mnemonic **"Can Carry Amino acids"** for the CCA tail at the 3' end. * **RNA Polymerases:** Know your types—Pol I (rRNA), Pol II (mRNA), Pol III (tRNA). * **Splicing:** Another major nuclear processing event involving snRNPs (Small Nuclear Ribonucleoproteins). * **Clinical Correlation:** Defects in tRNA processing are linked to mitochondrial encephalopathies (e.g., MELAS syndrome).

Question 489: Which type of RNA possesses the highest percentage of modified bases?

A. micro RNA (miRNA)
B. small nuclear RNA (snRNA)
C. transfer RNA (tRNA) (Correct Answer)
D. ribosomal RNA (rRNA)

Explanation: **Explanation:** **Transfer RNA (tRNA)** contains the highest percentage of modified bases among all RNA types. Approximately **10–15%** of the nucleotides in a mature tRNA molecule are modified post-transcriptionally. These modifications (over 100 types identified) are crucial for stabilizing the tRNA structure, ensuring precise codon-anticodon base pairing, and maintaining the fidelity of protein synthesis. Common examples include **pseudouridine (ψ)**, **dihydrouridine (D)**, and **ribothymidine (T)**, which give rise to the characteristic "TψC" and "D" loops in the cloverleaf model. **Analysis of Incorrect Options:** * **micro RNA (miRNA):** These are small non-coding RNAs (approx. 22 nucleotides) involved in gene silencing. While they undergo processing, they do not exhibit the extensive base modification seen in tRNA. * **small nuclear RNA (snRNA):** Found in spliceosomes, snRNAs do contain some modifications (like 2'-O-methylation and pseudouridylation), but the density is significantly lower than in tRNA. * **ribosomal RNA (rRNA):** rRNA is the most **abundant** RNA in the cell (80%). While it contains several modified bases (essential for ribosome assembly), the percentage relative to its large size is much lower than that of tRNA. **NEET-PG High-Yield Pearls:** * **Abundance Rule:** rRNA is the most **abundant**; tRNA is the **smallest** (75-95 nucleotides) and has the most **modified bases**; mRNA is the most **heterogeneous** in size. * **Solubility:** tRNA is also known as **"Soluble RNA" (sRNA)** because it does not precipitate even after centrifugation. * **Unusual Base:** The presence of **Pseudouridine** is a classic biochemical marker for tRNA identification in exams.

Question 490: Which of the following organelles is involved in the formation of N-glycosylated products?

A. Golgi apparatus (Correct Answer)
B. Nucleolus
C. Smooth Endoplasmic Reticulum
D. All of the above

Explanation: **Explanation:** Protein glycosylation is a post-translational modification essential for protein folding, stability, and cell signaling. It occurs primarily in the **Endoplasmic Reticulum (ER)** and the **Golgi apparatus**. **1. Why Golgi apparatus is correct:** N-glycosylation begins in the Rough ER, where a pre-formed oligosaccharide (dolichol-linked) is attached to an Asparagine residue. However, the **processing, trimming, and final maturation** of these N-linked glycans occur within the **Golgi apparatus**. The Golgi contains specific glycosyltransferases that add complex sugar chains (like galactose and sialic acid) to the core structure. Note: O-glycosylation (attachment to Serine/Threonine) occurs *exclusively* in the Golgi. **2. Why other options are incorrect:** * **Nucleolus:** This is the site of ribosomal RNA (rRNA) synthesis and ribosome assembly. It is not involved in protein modification or glycosylation. * **Smooth Endoplasmic Reticulum (SER):** The SER is primarily involved in lipid synthesis, steroid hormone production, and detoxification (Cytochrome P450 system). While the *Rough* ER initiates N-glycosylation, the SER does not play a significant role in this process. **High-Yield Clinical Pearls for NEET-PG:** * **I-Cell Disease (Inclusion Cell Disease):** A deficiency in *N-acetylglucosaminyl-1-phosphotransferase* in the Golgi. This prevents the phosphorylation of mannose residues (Mannose-6-Phosphate) on lysosomal enzymes, causing them to be secreted extracellularly rather than sent to lysosomes. * **Dolichol Phosphate:** The lipid carrier in the ER membrane required for the initial step of N-glycosylation. It is inhibited by the antibiotic **Tunicamycin**. * **N-linked** = Asparagine; **O-linked** = Serine/Threonine.

Practice by Chapter

DNA Replication and Repair Mechanisms

Practice Questions

Transcription Factors and Gene Regulation

Practice Questions

Epigenetics and DNA Methylation

Practice Questions

RNA Processing and Splicing

Practice Questions

miRNA and RNA Interference

Practice Questions

Protein Synthesis and Post-Translational Modifications

Practice Questions

Genomics and Human Genome Project

Practice Questions

Single Nucleotide Polymorphisms

Practice Questions

Gene Therapy Approaches

Practice Questions

CRISPR-Cas9 and Genome Editing

Practice Questions

DNA Fingerprinting and Forensics

Practice Questions

Molecular Basis of Genetic Diseases

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free